Representative Projects

Representative Projects

1. Government-, University- and Hospital-Supported Projects

Project 1

  • Project Title: Suzhou Industrial Park Affective Computing & Interactive Health Interdisciplinary Innovation (Research) Platform
  • Project Type: Governmental Research Project – SIP Construction of High-Level Innovation Platform
  • Project Period: 1 October 2025–30 September 2027, or 1 January 2026–31 December 2028; to be confirmed
  • Project Code: To be confirmed
  • Funding: RMB 1 million or RMB 800,000; to be confirmed
  • Principal Investigator: Zhijie Xu
  • Brief Description: The platform integrates multimodal affective computing, large language models, privacy-preserving edge AI, digital humans, medical visualisation and interactive rehabilitation. It provides an interdisciplinary foundation for mental wellbeing, healthy ageing and intelligent care.

Project 2

  • Project Title: Construction of an Artificial Intelligence Platform for Accurate Cytologic Screening of Cervical Cancer
  • Project Type: XJTLU Key Programme Special Fund – Applied Technology Research
  • Project Period: Commenced in 2020; completion date to be confirmed
  • Project Code: To be confirmed
  • Funding: RMB 1 million
  • Principal Investigator: Jionglong Su
  • Brief Description: The project develops AI methods for cervical cytology screening, including cell and chromosome analysis, image segmentation and decision support. It demonstrates a translational pathway from biomedical algorithms to a clinically relevant screening platform.

Project 3

  • Project Title: SWISS AI Foundation Model Research Grant
  • Project Type: SWISS AI Grant
  • Project Period: To be confirmed
  • Project Code: To be confirmed
  • Funding: CHF 80,000, stated as approximately RMB 650,000 in the submitted record
  • Principal Investigator: Xiaowu Sun
  • Collaborating Institution: Lausanne University Hospital (CHUV), Switzerland
  • Brief Description: The project develops foundation-model approaches for cardiovascular imaging in collaboration with CHUV. It builds on expertise in coronary angiography, cine CMR and 4D-flow MRI to support quantitative assessment, cross-centre validation and cardiovascular risk prediction.

Project 4

  • Project Title: Multi-Scale Language Models Collaboration for Multi-turn Empathetic Dialogue Generation
  • Project Type: National Natural Science Foundation of China – Young Scientists Fund
  • Project Period: 1 January 2026–31 December 2028
  • Project Code: 62502396
  • Funding: RMB 300,000
  • Principal Investigator: Yangbin Chen
  • Brief Description: The project investigates collaboration between language models of different scales to generate coherent, controllable and empathetic multi-turn dialogue. Applications include mental-health interviews, caregiver support, digital humans and embodied care agents.

Project 5

  • Project Title: Development of intelligent plastic paper splint in distal radius fracture
  • Project Type: Suzhou Traditional Chinese Medicine Hospital R&D Project
  • Project Period: 2024–2026
  • Project Code: To be confirmed
  • Funding: RMB 200,000
  • Principal Investigator: Jie Sun
  • Co-Principal Investigator: Qinglei Bu
  • Clinical Partner: Suzhou Traditional Chinese Medicine Hospital
  • Brief Description: The project combines a traditional fracture splint with sensing, IoT communication and remote monitoring. Pressure, posture and rehabilitation data can support safer treatment, personalised recovery assessment and future hospital validation.

Project 6

  • Project Title: Enhancing Depression Detection via Multimodal Data Fusion and Hierarchical Cross-Attention Networks
  • Project Type: XJTLU Research Development Fund
  • Project Period: 1 July 2025–30 June 2028
  • Project Code: RDF-24-02-008
  • Funding: RMB 100,000
  • Principal Investigator: Yangbin Chen
  • Brief Description: The project integrates speech, language, facial and video signals to support more objective assessment of depression. It provides a foundation for multimodal screening, longitudinal state modelling and clinically informed intelligent interaction.

Project 7

  • Project Title: Implementing Artificial Intelligence Models to Support Early Detection of Congenital Heart Defects in Routine Prenatal Ultrasound Scanning
  • Project Type: To be confirmed
  • Project Period: Active; formal dates to be confirmed
  • Project Code: To be confirmed
  • Funding: RMB 100,000
  • Principal Investigator: Netzahualcoyotl Hernandez-Cruz
  • Brief Description: The project investigates AI support for detecting congenital heart defects during routine prenatal ultrasound. It builds on fetal cardiac-view localisation and ultrasound-video analysis, with potential for wider clinical and resource-limited deployment.

Project 8

  • Project Title: Advancing Cancer Bioimage and Bioinformation Analysis through Artificial Intelligence Methods
  • Project Type: XJTLU Research Development Fund
  • Project Period: In progress; formal dates to be confirmed
  • Project Code: To be confirmed
  • Funding: RMB 100,000
  • Principal Investigator: Hejia Qiu
  • Brief Description: The project integrates cancer imaging, biological information and clinical data for prognosis and patient stratification. It supports interpretable tumour biomarkers and future studies of disease progression and treatment response.

2. Industry Partnerships and Joint Laboratories

Project 1

  • Project Title: XJTLU–Deepleaper Instant Knowledge Engine Joint Laboratory
  • Company: Deepleaper Pte. Ltd.
  • Project Type: University–Industry Joint Laboratory
  • Project Period: 2025–2030
  • Project Code: To be confirmed
  • Funding: RMB 5 million; contract confirmation required
  • Principal Investigator: Mian Zhou
  • Co-Principal Investigator: Jionglong Su
  • Brief Description: The laboratory develops knowledge engines, retrieval-augmented generation, continual learning and intelligent agents. These technologies can support biomedical evidence retrieval, clinical knowledge services, patient education and auditable research assistants.

Project 2

  • Project Title: XJTLU AIAC – Mind with Heart Robotics Co. Ltd. Embodied Emotional Intelligence Joint Lab
  • Flagship Project: An’an Cyber Panda
  • Company: Mind with Heart Robotics; legal company suffix to be confirmed
  • Project Type: University–Industry Joint Laboratory
  • Project Period: 2025–present
  • Project Code: To be confirmed
  • Funding: RMB 2 million; contract confirmation required
  • Principal Investigator: Jionglong Su
  • Brief Description: The laboratory combines multimodal perception, empathetic dialogue, robotics and human–robot interaction with industrial engineering and manufacturing. An’an provides an embodied platform for emotional support, elderly care and special-education research.

Project 3

  • Project Title: Development of an Interpretable System for Intelligent Multimodal Medical Diagnosis
  • Company: 南京朴归信息科技有限公司
    Official English company name was not provided in the submitted materials.
  • Project Type: Collaborative Research Project
  • Project Period: 18 September 2024–30 August 2028
  • Project Code: RDS10120240248
  • Funding: RMB 500,000
  • Principal Investigator: Haiyang Zhang
  • Brief Description: The project integrates medical images, clinical information and knowledge evidence within an interpretable diagnostic system. It focuses on causal de-biasing, uncertainty, explainability and reliability across datasets and healthcare settings.

Project 4

  • Project Title: Development of plant protein composite fiber scaffold solutions
  • Company: Suzhou Mingde Biotechnology Co.,Ltd
  • Project Type: Industry Collaborative Project
  • Project Period: June 2025–June 2028
  • Project Code: To be confirmed
  • Funding: RMB 500,000
  • Principal Investigator: Jie Sun
  • Brief Description: The project combines plant-protein biomaterials, fibre fabrication, machine learning and 3D biofabrication. It seeks to optimise scaffold composition, manufacturing parameters and biological performance for regenerative medicine and advanced tissue models.

Project 5

  • Project Title: To be confirmed
  • Company: Hansoh Pharmaceutical Group Company
  • Project Type: Industry Project
  • Project Period: December 2025–December 2026
  • Project Code: To be confirmed
  • Funding: RMB 385,000
  • Principal Investigator: Jingxin Liu
  • Brief Description: The collaboration applies digital pathology and medical AI to pharmaceutical research and biomarker assessment. Relevant technical strengths include histochemical scoring, PD-L1 quantification, cellular analysis, cross-stain segmentation and virtual staining.